AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8770718 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity antidepressant treatment (dosage not specified)
Number of subjects: 88
Study 8770718 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity treatment
Number of subjects: 88
Study 8770718 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-intensity treatment
Number of subjects: 88
Study 2292546 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin
Number of subjects: 35
Study 2292546 — intervention group
Group type: COMPARATOR
Intervention: Intraperitoneal vancomycin/netilmicin
Number of subjects: 35
Study 7006619 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol, given four times daily
Number of subjects: 14
Study 7006619 — intervention group
Group type: COMPARATOR
Intervention: Penbutolol, given once daily
Number of subjects: 14
Study 31614329 — intervention group
Group type: EXPERIMENTAL
Intervention: Tart Cherry Juice (TCJ)
Number of subjects: 20
Study 31614329 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 20
Study 29860661 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 mg vitamin C daily 2 days after RAIT
Number of subjects: 58
Study 29860661 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 mg vitamin C daily 2 days before to 2 days after RAIT
Number of subjects: 58
Study 29860661 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 mg vitamin C daily 2 days before RAIT
Number of subjects: 58
Study 29860661 — intervention group
Group type: COMPARATOR
Intervention: Control group (RAIT without vitamin C)
Number of subjects: 58
Study 28450772 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine + Dexmedetomidine (Group D)
Number of subjects: 70
Study 28450772 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine + Normal Saline (Group C)
Number of subjects: 70
Study 24200715 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent and intermittent atrioventricular (AV) block
Number of subjects: 1808
Study 24200715 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial fibrillation with slow ventricular rate
Number of subjects: 1808
Study 24200715 — intervention group
Group type: EXPERIMENTAL
Intervention: Miscellaneous bradyarrhythmias
Number of subjects: 1808
Study 24200715 — intervention group
Group type: EXPERIMENTAL
Intervention: Left bundle branch block
Number of subjects: 1808
Study 24200715 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial tachyarrhythmias
Number of subjects: 1808
Study 21822593 — intervention group
Group type: EXPERIMENTAL
Intervention: THC (Δ(9)‐tetrahydrocannabinol)
Number of subjects: 11
Study 21822593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 20093335 — intervention group
Group type: EXPERIMENTAL
Intervention: Subzero-balanced ultrafiltration
Number of subjects: 120
Study 20093335 — intervention group
Group type: COMPARATOR
Intervention: Routine cardiopulmonary bypass
Number of subjects: 120
Study 17192497 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg intranasal ketorolac
Number of subjects: 15
Study 17192497 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg intranasal ketorolac
Number of subjects: 15
Study 17192497 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg intramuscular ketorolac
Number of subjects: 15
Study 17192497 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg intramuscular ketorolac
Number of subjects: 15
Study 17192497 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal ketorolac (both doses)
Number of subjects: 15
Study 17192497 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal ketorolac
Number of subjects: 15
Study 15292384 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemotherapy (MeCCNU, vincristine, 5-fluorouracil)
Number of subjects: 1166
Study 15292384 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant immunotherapy (bacillus Calmette‐Guérin)
Number of subjects: 1166
Study 15292384 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery alone
Number of subjects: 1166
Study 11800507 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg 5 nights/week
Number of subjects: 789
Study 11800507 — intervention group
Group type: COMPARATOR
Intervention: Placebo 2 nights/week
Number of subjects: 789
Study 10526810 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (1, 2, 3, 4, 5, or 6 micrograms/ml) and Sufentanil (0.1, 0.2, 0.3, 0.5, or 1.0 ng/ml) target blood concentrations
Number of subjects: 30
Study 7677489 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited resection (segment or wedge)
Number of subjects: 247
Study 7677489 — intervention group
Group type: COMPARATOR
Intervention: Lobectomy
Number of subjects: 247
Study 2264951 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen 40 mg/day
Number of subjects: 5
Study 2264951 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen 80 mg/day
Number of subjects: 5
Study 2264951 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 5
Study 375802 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin, 1 gm intramuscularly preoperatively, then 0.5 gm every six hours for four doses
Number of subjects: 55
Study 375802 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 31705685 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-tail rope assistance (group A)
Number of subjects: 301
Study 31705685 — intervention group
Group type: COMPARATOR
Intervention: Unassisted recovery (group U)
Number of subjects: 301
Study 31815615 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic-based self-sampling
Number of subjects: 3550
Study 31815615 — intervention group
Group type: EXPERIMENTAL
Intervention: Mail-out self-sampling
Number of subjects: 3550
Study 31815615 — intervention group
Group type: COMPARATOR
Intervention: Usual care (clinician-collected cytology test)
Number of subjects: 3550
Study 28866743 — intervention group
Group type: COMPARATOR
Intervention: 20 mg THC
Number of subjects: 15
Study 28866743 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 25528432 — intervention group
Group type: EXPERIMENTAL
Intervention: High-oleic canola oil
Number of subjects: 50
Study 25528432 — intervention group
Group type: COMPARATOR
Intervention: Corn/safflower oil
Number of subjects: 50
Study 25528432 — intervention group
Group type: COMPARATOR
Intervention: DHA-enriched high oleic canola oil
Number of subjects: 50
Study 23656989 — intervention group
Group type: EXPERIMENTAL
Intervention: Microglial response to dense-core plaques
Number of subjects: 40
Study 23656989 — intervention group
Group type: EXPERIMENTAL
Intervention: Astrocytic response to dense-core plaques
Number of subjects: 40
Study 21385856 — intervention group
Group type: EXPERIMENTAL
Intervention: oral 6‐mercaptopurine and intramuscular methotrexate (arm 1)
Number of subjects: 807
Study 21385856 — intervention group
Group type: EXPERIMENTAL
Intervention: ATRA alone (arm 2)
Number of subjects: 807
Study 21385856 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months of arm 1 alternating to 15 days of arm 2 (arm 3)
Number of subjects: 807
Study 21385856 — intervention group
Group type: COMPARATOR
Intervention: no further therapy (arm 4)
Number of subjects: 807
Study 19106352 — intervention group
Group type: EXPERIMENTAL
Intervention: MCA training module
Number of subjects: 6
Study 16472976 — intervention group
Group type: EXPERIMENTAL
Intervention: Branched-chain-enriched amino acid mixture infused at 82 mg x h(‐1) x kg(‐1) for 3 hours
Number of subjects: 0
Study 16472976 — intervention group
Group type: COMPARATOR
Intervention: Balanced amino acid infusion
Number of subjects: 0
Study 16472976 — intervention group
Group type: EXPERIMENTAL
Intervention: Branched-chain-enriched amino acid mixture
Number of subjects: 0
Study 16472976 — intervention group
Group type: COMPARATOR
Intervention: Balanced amino acid mixture
Number of subjects: 0
Study 10809242 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 L dialysate fill volume
Number of subjects: 81
Study 10809242 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 L dialysate fill volume
Number of subjects: 81
Study 10809242 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0 L dialysate fill volume
Number of subjects: 81
Study 8752629 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg of dexamethasone
Number of subjects: 99
Study 8752629 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dexamethasone)
Number of subjects: 99
Study 1846981 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin/etoposide/vincristine (CEV)
Number of subjects: 0
Study 1846981 — intervention group
Group type: COMPARATOR
Intervention: Etoposide/vincristine
Number of subjects: 0
Study 6340970 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg tiaprofenic acid daily for 3 months
Number of subjects: 60
Study 6340970 — intervention group
Group type: COMPARATOR
Intervention: 100 mg indomethacin daily for 3 months
Number of subjects: 60
Study 31585976 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency caesarean delivery
Number of subjects: 347
Study 31585976 — intervention group
Group type: COMPARATOR
Intervention: Elective caesarean delivery
Number of subjects: 347
Study 31585976 — intervention group
Group type: EXPERIMENTAL
Intervention: Future mode of birth preference
Number of subjects: 347
Study 31585976 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to participate in a randomised trial
Number of subjects: 347
Study 30025937 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication intervention
Number of subjects: 537
Study 27038153 — intervention group
Group type: EXPERIMENTAL
Intervention: Action Observation + Repeated Practice (AO+RP)
Number of subjects: 70
Study 27038153 — intervention group
Group type: COMPARATOR
Intervention: Repeated Practice (RP) alone
Number of subjects: 70
Study 24785926 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-cured glass ionomer cement (Transbond Plus Light Cure Band Adhesive; 3M Unitek) bonded onto the occlusal surface of the mandibular first premolar for 4 weeks.
Number of subjects: 12
Study 24785926 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention on one side of each patient).
Number of subjects: 12
Study 23009579 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia Quality of life Instrument (DQI)
Number of subjects: 145
Study 23009579 — intervention group
Group type: EXPERIMENTAL
Intervention: DQI
Number of subjects: 145
Study 20003116 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen (inspired O(2) fraction 0.80)
Number of subjects: 9
Study 20003116 — intervention group
Group type: COMPARATOR
Intervention: Medical air (inspired O(2) fraction 0.21)
Number of subjects: 9
Study 18160927 — intervention group
Group type: EXPERIMENTAL
Intervention: Point injection
Number of subjects: 69
Study 18160927 — intervention group
Group type: COMPARATOR
Intervention: Traditional acupuncture
Number of subjects: 69
Study 16336289 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary Rehabilitation Programme (PRP)
Number of subjects: 50
Study 16336289 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium therapy alone (Control)
Number of subjects: 50
Study 12208407 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG-tilt)
Number of subjects: 96
Study 12208407 — intervention group
Group type: COMPARATOR
Intervention: Passive tilt
Number of subjects: 96
Study 12208407 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol (ISO-tilt)
Number of subjects: 96
Study 12208407 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG-tilt) in patients with positive passive tilt response
Number of subjects: 96
Study 12208407 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol (ISO-tilt) in patients with positive passive tilt response
Number of subjects: 96
Study 12208407 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG-tilt) in patients with negative passive tilt response
Number of subjects: 96
Study 12208407 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol (ISO-tilt) in patients with negative passive tilt response
Number of subjects: 96
Study 10688525 — intervention group
Group type: EXPERIMENTAL
Intervention: Five consecutive trials of hyperventilation with cognitive restructuring instructions
Number of subjects: 0
Study 10688525 — intervention group
Group type: COMPARATOR
Intervention: Five consecutive trials of voluntary hyperventilation
Number of subjects: 0
Study 7602022 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient consultative geriatric assessment
Number of subjects: 442
Study 31016610 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance
Number of subjects: 105
Study 31016610 — intervention group
Group type: EXPERIMENTAL
Intervention: Reappraisal
Number of subjects: 105
Study 31016610 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 105
Study 31194943 — intervention group
Group type: EXPERIMENTAL
Intervention: Early clinical assessment of dysphagia before oral intake; therapeutic interventions implemented immediately for diagnosed dysphagia
Number of subjects: 438
Study 31194943 — intervention group
Group type: COMPARATOR
Intervention: Control group (no early assessment of dysphagia)
Number of subjects: 438
Study 28244408 — intervention group
Group type: EXPERIMENTAL
Intervention: GemX (gemcitabine chemotherapy at 100 mg/m2 with concurrent radiation therapy at a total dose of 52.5 Gy in 20 fractions)
Number of subjects: 78
Study 28244408 — intervention group
Group type: EXPERIMENTAL
Intervention: neoGemX (gemcitabine chemotherapy at 100 mg/m2 with concurrent radiation therapy at a total dose of 52.5 Gy in 20 fractions following NAC)
Number of subjects: 78
Study 28244408 — intervention group
Group type: COMPARATOR
Intervention: GemX
Number of subjects: 78
Study 28244408 — intervention group
Group type: COMPARATOR
Intervention: neoGemX
Number of subjects: 78
Study 28244408 — intervention group
Group type: EXPERIMENTAL
Intervention: GemX and neoGemX
Number of subjects: 78
Study 26718518 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy with clopidogrel (triple-C)
Number of subjects: 11756
Study 26718518 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy with prasugrel (triple-P)
Number of subjects: 11756
Study 26718518 — intervention group
Group type: COMPARATOR
Intervention: Dual therapy with clopidogrel (dual-C)
Number of subjects: 11756
Study 26718518 — intervention group
Group type: COMPARATOR
Intervention: Dual therapy with prasugrel (dual-P)
Number of subjects: 11756
Study 26718518 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy (both triple-C and triple-P)
Number of subjects: 11756
Study 22892368 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-sugar (MS) test (1 g sucrose, lactulose, sucralose, erythritol, 0.5 g rhamnose in water) after indomethacin
Number of subjects: 10
Study 22892368 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual sugar (DS) test (5 g lactulose, 0.5 g rhamnose) after indomethacin
Number of subjects: 10
Study 22892368 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MS and DS tests after indomethacin
Number of subjects: 10
Study 22892368 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-sugar (MS) test
Number of subjects: 10
Study 22892368 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual sugar (DS) test
Number of subjects: 10
Study 21193619 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephonic intervention
Number of subjects: 526
Study 21193619 — intervention group
Group type: COMPARATOR
Intervention: Print intervention
Number of subjects: 526
Study 19059855 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Case Management (ICM)
Number of subjects: 302
Study 19059855 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (screen-and-refer program)
Number of subjects: 302
Study 17313722 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy meal course (2090 kJ/meal)
Number of subjects: 13
Study 17313722 — intervention group
Group type: COMPARATOR
Intervention: Control meal (2090 kJ/meal)
Number of subjects: 13
Study 15471656 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (20 mg/day)
Number of subjects: 51
Study 15471656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 11915694 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthoptic exercises and near point exercises at home (Group 1, 34 patients)
Number of subjects: 162
Study 11915694 — intervention group
Group type: EXPERIMENTAL
Intervention: Only near point exercises at home (Group 2, 34 patients)
Number of subjects: 162
Study 11915694 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control Group 3, 30 patients)
Number of subjects: 162
Study 9876450 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood samples drawn from femoral and brachial veins after 30 minutes in reverse Trendelenburg position
Number of subjects: 19
Study 7976142 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 ml 0.5% lidocaine with 2 mg of atracurium
Number of subjects: 40
Study 7976142 — intervention group
Group type: COMPARATOR
Intervention: 40 ml 0.5% lidocaine
Number of subjects: 40
Study 2597711 — intervention group
Group type: EXPERIMENTAL
Intervention: Current feedback (accurate information regarding blood glucose levels)
Number of subjects: 36
Study 2597711 — intervention group
Group type: COMPARATOR
Intervention: Noncurrent feedback (blood glucose levels from the preceding session)
Number of subjects: 36
Study 1020593 — intervention group
Group type: EXPERIMENTAL
Intervention: Heineke-Mikulicz (HM) pyloroplasty
Number of subjects: 170
Study 1020593 — intervention group
Group type: COMPARATOR
Intervention: Finney (F) pyloroplasty
Number of subjects: 170
Study 1020593 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 170
Study 30789546 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent meetings attendance
Number of subjects: 39
Study 30789546 — intervention group
Group type: EXPERIMENTAL
Intervention: Preschooler letters
Number of subjects: 39
Study 30789546 — intervention group
Group type: EXPERIMENTAL
Intervention: Preschooler program attendance
Number of subjects: 39
Study 27783162 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous closed-suction drainage arm
Number of subjects: 240
Study 27783162 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no subcutaneous drainage)
Number of subjects: 240
Study 26636533 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Group D)
Number of subjects: 70
Study 26636533 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil (Group R)
Number of subjects: 70
Study 26636533 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 70
Study 22960239 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent traction
Number of subjects: 98
Study 22960239 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous traction
Number of subjects: 98
Study 22960239 — intervention group
Group type: COMPARATOR
Intervention: Control (hot pack and short wave diathermy)
Number of subjects: 98
Study 21519837 — intervention group
Group type: EXPERIMENTAL
Intervention: CEF adjuvant chemotherapy
Number of subjects: 477
Study 21519837 — intervention group
Group type: COMPARATOR
Intervention: CMF adjuvant chemotherapy
Number of subjects: 477
Study 18370574 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole (5-30 mg/day)
Number of subjects: 62
Study 18370574 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 16565827 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (7 or 14 mg)
Number of subjects: 34
Study 16565827 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 14514591 — intervention group
Group type: EXPERIMENTAL
Intervention: HYAFF 11-based autologous dermal and epidermal grafts
Number of subjects: 79
Study 14514591 — intervention group
Group type: COMPARATOR
Intervention: Nonadherent paraffin gauze (Control)
Number of subjects: 79
Study 11090796 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-minute determination of ST-segment resolution after thrombolytic therapy
Number of subjects: 0
Study 11090796 — intervention group
Group type: COMPARATOR
Intervention: 90-minute determination of ST-segment resolution after thrombolytic therapy
Number of subjects: 0
Study 8937904 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatric consultation intervention
Number of subjects: 104
Study 8937904 — intervention group
Group type: COMPARATOR
Intervention: Control group (no psychiatric consultation)
Number of subjects: 104
Study 8937904 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (psychiatric consultation)
Number of subjects: 104
Study 1526219 — intervention group
Group type: EXPERIMENTAL
Intervention: 3,4-diaminopyridine
Number of subjects: 1
Study 1526219 — intervention group
Group type: EXPERIMENTAL
Intervention: 3,4-diaminopyridine + anti-cholinesterase medication
Number of subjects: 1
Study 1526219 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study 2989052 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g bran daily
Number of subjects: 200
Study 2989052 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dietary supplement)
Number of subjects: 200
Study 2989052 — intervention group
Group type: EXPERIMENTAL
Intervention: Dropouts (bran group)
Number of subjects: 200
Study 2989052 — intervention group
Group type: EXPERIMENTAL
Intervention: Refusers (bran group)
Number of subjects: 200
Study 2989052 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants (bran group)
Number of subjects: 200
Study 31501094 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 94
Study 29126173 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated poliovirus vaccine (IPV) at all time points (Arm A)
Number of subjects: 0
Study 29126173 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalent oral poliovirus vaccine (bOPV) at all time points (Arm B)
Number of subjects: 0
Study 29126173 — intervention group
Group type: EXPERIMENTAL
Intervention: bOPV at first 3 time points and bOPV plus IPV at final time point (Arm C)
Number of subjects: 0
Study 29126173 — intervention group
Group type: EXPERIMENTAL
Intervention: bOPV at first 3 time points and bOPV plus IPV at final time point (Arm D)
Number of subjects: 0
Study 29126173 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent OPV (tOPV) at all time points (Arm E)
Number of subjects: 0
Study 29126173 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated poliovirus vaccine (IPV) at final time point (Arm D)
Number of subjects: 0
Study 29126173 — intervention group
Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 0